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Welcome to New York City! We 
are thrilled to have you at the 45th 
Controlled Release Society Annual 
Meeting and Exposition (#CRSNYC). 
Over the next 3 days, you will have access 
to world-renowned speakers, cutting-edge 
research, 100+ educational offerings, and 
endless networking opportunities with the 
best and brightest in delivery science.
I am also thrilled to announce the significant 
re-invigoration that will be launching right 
here at the annual meeting, CRS Focus 
Groups. The focus groups are centered 
around the areas of Ocular Drug Delivery 
(OcDD), Oral Drug Delivery (OrDD), 
Nanomedicine and Nanoscale Drug 
Delivery (NNDD), Gene Delivery and 
Gene Editing (GDE), Bioinspired and 
Biomimetic Drug Delivery (BBDD), and 
will provide leadership opportunities 
for young scientists. The initiator and 
frontrunner of this re-invigoration is Steven 
R. Little (University of Pittsburgh, U.S.A.).
I am extremely grateful for the 
tremendous work of the members of the 
Program Committee in preparing an 
outstanding 2018 CRS Annual Meeting. 
Committee includes: Chair – Hamid 
Ghandehari (University of Utah, U.S.A.); 
Co-Chairs - Twan Lammers (RWTH 
Aachen University, Germany), Yu-
Kyoung Oh (Seoul National University, 
South Korea); Members - Thierry 
Vandamme (Université de Strasbourg, 
France), Tapashi Sengupta (Monsanto 
Company, U.S.A.), Kaushalkumar 
Dave (United States Food and Drug 
Administration, U.S.A.).
The Controlled Release Society 
is, in my opinion, one of the most 
respected and unique societies 
that covers new technologies and 
science in the multi-disciplinary 
delivery fields. CRS has succeeded 
in fostering significant progress 
in the areas of bioengineering, drug delivery, 
material science, pharmaceutics, consumer and 
diversified products, and veterinary science. 
With members in more than 30 countries, 
as well as 15 local chapters throughout the 
world, our excellent annual meetings, and 
two prestigious CRS journals, the Journal of 
Controlled Release (impact factor in 2018 of 
7.877, Editor-in-Chief Kinam Park) and the 
recently established journal Drug Delivery and 
Translational Research (impact factor in 2017 of 
3.094, Editor-in-Chief Vinod Labhasetwar), we 
can look to the Society’s future with deserved 
optimism.
If you’re not already a member, now is the 
ideal time to become a part of the Controlled 
Release Society. Through our collective efforts, 
we can raise CRS and the existing science and 
technology we are involved in to a new level.
I look forward to connecting with you here in 
New York City.
Sincerely,
Tamara Minko, Ph.D. 
President of the CRS
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CRS Headquarters Staff is Ready to Serve You!
CRS headquarters staff values current members and meeting participants and future members and meeting attendees. 
Our goal is to consistently provide you outstanding service, products, and programs. Use the following quick reference list 
to reach the appropriate persons in areas in which you may need assistance. Please call the general number for assistance 
Monday through Friday during the office hours of 08:30 AM – 4:30 PM Eastern Time. Remember, you can leave a voice mail 
or e-mail message at any time. We look forward to hearing from you!
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All events will take place at the New York Hilton Midtown 
in New York City, July 22 – 24, 2018
Registration Hours
The registration desk will be open during the following hours: 
(Hours are subject to change)
Saturday, July 21st – 7:00 AM – 5:00 PM 
Sunday, July 22nd– 7:00 AM – 5:00 PM 
Monday, July 23rd – 7:00 AM – 5:00 PM 
Tuesday, July 24th – 7:00 AM – 4:00 PM
Use of CRS Scientific Program Content
Information presented during the 2018 CRS Annual Meeting 
& Exposition is the property of CRS and the presenter. 
Information may not be recorded, photographed, copied, 
photocopied, transferred to electronic format, reproduced, 
or distributed without the written permission of CRS and the 
presenter. Any use of the program content, which includes, 
but is not limited to oral presentations, audiovisual materials 
used by speakers, and program handouts, without the 
written consent of CRS is prohibited.
Speaker Ready Room Hours:
Saturday, July 21st – 7:00 AM – 5:00 PM 
Sunday, July 22nd– 7:00 AM – 5:00 PM 
Monday, July 23rd – 7:00 AM – 5:00 PM 
Tuesday, July 24th – 7:00 AM – 4:00 PM
The Speaker Ready Room is located in Holland Room.  
The Speaker Ready Room is provided for presenters to 
prepare for their presentations and to ensure a seamless 
integration of a wide variety of audiovisual technologies in 
the various meeting rooms. By checking in at the Speaker 
Ready Room and following these simple guidelines, speakers 
will greatly contribute to the success of the meeting. CRS 
requests all presenters to use PowerPoint™ Presentations. 
All meeting rooms will have presentation computers and will 
be networked from a central computer located in the Speaker 
Ready Room. Presentations will be downloaded from the 
Speaker Ready Room and sent to the respective meeting 
room on a secured intranet circuit approximately 45 minutes 
prior to the start of each session. Presenters are encouraged 
to review their presentations or make any last minute changes. 
All speakers must check into the Speaker Ready Room.
Access the Abstracts
CRS annual meeting abstracts can easily be accessed on 
the CRS Meeting App. Within the app, click on the Posters 
icon to begin viewing poster abstracts, and view podium 
abstracts directly from the schedule. The abstracts will be 
available on the CRS website after the meeting.
Electronic Devices
As a courtesy to other meeting attendees, please turn 
off or silence all electronic devices during all workshops, 
sessions, and presentations.
Photography
Photography is not permitted in the session rooms,  
exhibit hall, or poster sessions.
Photo Release
By virtue of your attendance, you agree to the Controlled 
Release Society’s use of your likeness in promotional media.
Children and the CRS Annual Meeting 
& Exposition
The CRS Annual Meeting & Exposition is a professional, 
scientific meeting. CRS does not permit anyone under the 
age of 18 to attend the scientific sessions, poster sessions, 
exposition, and social events. For safety reasons, only 
registered exhibitors and poster presenters are permitted 
in the exposition/poster hall during set-up and take-down 
hours. Anyone 18+ must register and buy applicable 
individual tickets if not attending/registering as a student.
CRS Antitrust Policy 
It is the undeviating policy of the Controlled Release 
Society (CRS) to comply strictly with the letter and spirit 
of all United States federal laws, as well as state, and 
applicable international trade regulations and antitrust 
laws. Any activities of CRS or related actions of its staff, 
officers, trustees, or members that violate these laws and 
regulations are detrimental to the interests of CRS and are 
unequivocally contrary to CRS’ policy.
The implementation of the antitrust compliance policy of 
CRS shall include, but not be limited to the following:
a.  All the association activities or discussions shall be 
avoided that might be construed as tending to: (1) 
raise, lower, or stabilize prices; (2) allocate markets; (3) 
encourage boycotts, (4) foster unfair trade practices; 
or (5) in any way violate US federal, state, or applicable 
international trade regulations and antitrust laws.
b.  No officer, director, or member of CRS shall make any 
representation in public or in private, orally or in writing, 
that states, or appears to state, an official policy or 
position of CRS without specific authorization to do so
c.  CRS members, officers, or directors who participate 
in conduct that the Board of Directors, by a two-thirds 
majority vote, determine to be contrary to the CRS 
Antitrust Policy shall be subject to disciplinary measures 
up to, and including, termination.
GENERAL MEETING INFORMATION
5
COLLABORATE • CONNECT • INNOVATE
Exhibits
The exhibits are an integral part of the complete education 
experience and will feature the latest in research products 
in the field of osteoarthritis. Please make time during the 
meeting to visit the exhibits during their open hours. They 
are located in Rhinelander Gallery.
Monday  9:00 AM – 4:30 PM 
5:00 PM – 6:00 PM
Tuesday  9:00 AM – 4:00 PM
Our Sunday evening opening reception will be held in the 
exhibit hall as well as all breaks beginning on Monday. 
Poster Sessions
Posters are located in Rhinelander Gallery, Gramercy, and 
Murray Hill Rooms, on the second floor of the hotel. All 
posters must be removed during Poster Take-Down or they 
will be discarded. The poster viewing area will be secured 
overnight. Photographing posters is not permitted.
The Posters Sessions are an important educational event 
of this meeting. We hope you support and attend these 
scientific presentations. Poster board numbers correspond 
with the poster numbers in CRS Mobile App.
Posters will be displayed during the entire meeting. Listed 
below is the schedule when authors are to be present with 
their poster.
Monday, July 23, 2018 – Authors will be with the posters 
Odd Posters 12:30 PM – 1:30 PM
Tuesday, July 24, 2018 – Authors will be with the posters 
Even Posters 12:30 PM – 1:30 PM
Monday, July 23, 2018 
POSTER PUB – 5:00 PM – 6:00 PM 
All posters presented – All Authors will be with the posters
ALL POSTERS MUST BE TAKEN DOWN BY 5:00 PM  





The Distinguished Service Award is presented to a CRS 
member who has exhibited exceptional commitment  
and service to the society and is selected by the 
Board of Directors.
Ruth Schmid. PhD 
SINTEF Industry
College of Fellows
The College of Fellows recognizes those members who 
have made outstanding contributions to the field of 
delivery science and technology over a minimum of 10 
years. Contributions may have been technical, scientific, 
and/or managerial in one or more fields of research, 
commercial development, education, and/or leadership 
within the areas of interest to CRS. Fellowship is the most 
prestigious level of membership in CRS.
Maria José Alonso, PhD 
University of Santiago de Compostela
Ben J. Boyd, PhD 
Monash Institute of Pharmaceutical Sciences
Alexander Kabanov, PhD, DSC 
University of North Carolina, Chapel Hill
Mark Prausnitz, PhD 
Georgia Institute of Technology
Mark A. Tracy, PhD 
Tracy BioConsulting, LLC
Founders Award
The society grants this honor to a current CRS member 
who is internationally recognized for outstanding 
contributions in the science and technology of  
controlled release.
Maria José Alonso, PhD 
University of Santiago de Compostela
CRS T. Nagai Postdoctoral Research  
Achievement Award
This award recognizes an individual postdoc who has 
recently completed postdoctoral research in controlled 
release science and technology and the postdoc’s advisor, 
who played an integral role in the achievements.
Raghu Ganugula – Post-Doc 
Texas A&M University
Ravikumar Majeti, PhD – Sponsor 
Texas A&M University
Young Investigator Award
This award recognizes a CRS member who has made 
outstanding contributions in the science of controlled 
release and is 40 years of age or younger in the year the 
award is presented.
Steven R. Little, PhD 
University of Pittsburgh
Transdermal Delivery Kydonieus Foundation
Richard H. Guy, PhD 
University of Bath




Co-Authors: Nina R Derby, Meropi Aravantinou, 
Jessica Kenney, Shweta R. Ugaonkar, Asa Wesenberg, 
Jolanta Wilk, Larisa Kizima, Aixa Dones Rodríguez, 
Shimin Zhang, Olga A Mizenina, Keith Levendosky, Michael 
L. Cooney, Samantha Seidor, Agegnehu Gettie, Brooke 
Grasperge, James D. Blanchard, Michael J. Piatak, Jeffrey 
D Lifson, José A Fernández-Romero, Thomas M. Zydowsky, 
Melissa Robbiani
An intravaginal ring that releases three antiviral agents and 
a contraceptive blocks SHIV-RT infection, reduces HSV-
2 shedding, and suppresses hormonal cycling in rhesus 
macaques
2018 CRS AWARDS & RECOGNITION
Congratulations to the 2018 Award Winners
CRS is honored to continue the tradition of recognizing the excellence of our members. Please be sure to attend the award 
ceremony on Sunday, July 22, 2018, in the Grand Ballroom at 12:30 PM and personally congratulate the awardees on their 
well-earned commendation. Find full biographies of awardees on the CRS website.
COLLABORATE • CONNECT • INNOVATE
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CRS BOARD  and COMMITTEE MEETINGS
2018 CRS AWARDS & RECOGNITION
FRIDAY, JULY 20th TIME ROOM
CRS Strategic Planning Session 9:00 AM – 3:00 PM Hilton Board Room
SATURDAY, JULY 21st TIME ROOM
CRS Board of Directors Meeting 8:00 AM – 6:00 PM Hilton Board Room
SUNDAY, JULY 22nd TIME ROOM
Leadership Forum 9:00 AM – 11:00 AM Nassau East
2019 AMPC Planning Meeting 10:30 AM – 12:30 PM Hilton Board Room
Local Chapters Meet & Greet 11:00 AM – 12:30 PM Nassau West
MONDAY, JULY 23rd TIME ROOM
Elsevier Editorial Board Meeting – JCR 12:00 PM – 1:30 PM Bryant Room
TUESDAY, JULY 24th TIME ROOM
C&DP Division Meeting 7:00 AM – 8:00 AM Morgan Room
Springer Editorial Board Meeting – DDTR 7:00 AM – 8:30 AM Bryant Room
Industry Advisory Meeting 12:00 PM – 1:30 PM Clinton Room
Elsevier Editorial Board Meeting – ADDR 12:00 PM – 1:30 PM Bryant Room
CRS Board Meeting 4:30 PM – 6:00 PM New York




Co-Authors: Simona Mancini, Cladia Balducci, 
Edoardo Micotti, Daniele Tolomeo, Gianluigi Forloni, 
Francesca Re
Multifunctional liposomes delay phenotype progression 
and prevent memory impairment in a presymptomatic 






















Saturday, July 21 | Program
PRE-MEETING WORKSHOPS
Oral Peptide Delivery: A Follow-Up From CRS 2014 
(Part 1) 
8:30 AM – 5:00 PM | Sutton South
Sponsored by:
Basic Concepts of Oral Drug Delivery;  
What You Need to Know 
9:00 AM – 5:00 PM | Sutton Center
Sponsored by:
Nanomedicine From Bench To Bedside –  
Facilitating Research Translation To Clinics 
Young Scientist Workshop 
1:00 PM – 5:00 PM | Beekman Room
This CRS-YSC organized Scientific Workshop aims to 
provide researchers an opportunity to gain knowledge and 
understanding of clinical translation of nanomedicines. 
The workshop will bring together experts and scientists in 
nanomedicine to discuss a range of topics including:
•   Lab scale development to industrial scale up, 
manufacturing and translation
•   Standardization and characterization from basic research 
to clinical development
•   Preclinical, clinical, and safety considerations in the 
development process
•   Regulatory challenges for development and 
commercialization
*All workshops require a paid ticket to attend. 
Tickets can be purchased at the registration desk.
Sunday, July 22 | Morning Program
PRE-MEETING WORKSHOPS
Oral Peptide Delivery; A Follow-Up From CRS 2014 
(Part 2) 
8:00 AM – 12:30 PM | Sutton South
Sponsored by:
Young Scientist Professional Development Workshop: 
Enhancing your Networking and Communication Skills 
8:00 AM – 11:30 AM | Regent Room
Have you ever felt you could get more out of your career? 
Are you close to graduating, about to start a new job, or 
just thinking about making a change? If so, this workshop 
is for you! This interactive session will discuss key factors 
for professional success, including effective communication 
skills, successful networking strategies, establishing 
professional collaborations, and improving your leadership 
skills. In this workshop, you will receive tips on how 
to boost your career in these areas, and be given the 
opportunity to practice some strategies that will help you 
pave the way for a bright future, full of achievements.
TECHNOLOGY FORUMS* 
8:30 AM – 12:15 PM 
*Please see page 9 for Technology Forum details
LOCAL CHAPTERS MEET & GREET 
11:00 AM – 12:30 PM | Nassau West
YOUNG SCIENTIST MEET & GREET WITH A LUMINARY 
Rakesh Jain 
11:30 AM – 12:30 PM | Beekman Room
OPENING SESSION & AWARDS CEREMONY 
12:30 PM – 1:30 PM | Grand Ballroom 
President: Tamara Minko, Rutgers University, U.S.A.
PLENARY SESSION 1 
Moderated by: Yoon Yeo, Purdue 
University, U.S.A. 
A Long Walk to PLGA 
1:30 PM – 2:30 PM | Grand Ballroom 
Kinam Park 
Purdue University, U.S.A.
Followed by An Interactive Session with Kinam Park 
2:30 PM – 3:00 PM | Grand Ballroom 
At the end of the lecture, attendees can meet and greet 
with Kinam Park to ask questions related to the scope of 
the talk, the science discussed, career advice, etc. This will 
be done in an informal and interactive setting.
REFRESHMENT BREAK 
2:30 PM – 3:00 PM | 2nd Floor Promenade
CONCURRENT SESSIONS 
3:00 PM – 5:00 PM 
See pages 10 & 11 for details.














Sunday, July 22 | Technology Forums
Open to all registered attendees on a complimentary basis, these forums offer in-depth coverage of technologies and 
services hosted by the presenting companies. Detailed descriptions of the individual forums can be found on the CRS 
Meeting App.
11:15 AM to 12:15 PM
EUDRATEC® PEP - An Innovative Smart Oral Delivery 
Technology for Proteins and Peptides 
Bryant Room
Strategies for the Formation and Coating of 
Multiparticulates for use in modified release products 
using the Conical Rotor Processor 
Madison Room
Trends in Small Volume Dissolution 2018 
Morgan Room
Use of canine PK/ PD models in the development of 
differentiated drug products. 
Clinton Room
8:30 AM to 9:30 AM
Single Particle Zeta Potential Characterization of 
Biological Nanoparticles using Tunable Resistive Pulse 
Sensing (TRPS) 
Madison Room
Meeting the Formulation Challenges of Bitter 
Tasting Drugs 
Morgan Room
9:45 AM to 10:45 AM
EUDRAGIT® Solid Dispersions as Carriers for Solubility 
Enhancement of Poorly Water Soluble Drugs 
Bryant Room
Characterizing Controlled Release Vehicles 
Madison Room
High-Throughput or Well-Characterized? Light 
Scattering Tools for Rapid Screening and Deep 
Characterization of Therapeutic Nanoparticles 
Morgan Room
Innovations in Drug Delivery 
Clinton Room
Designing Patient Friendly Dosage Forms to Target the Unique Therapeutic Needs of the 














Sunday, July 22 | 3:00 PM – 5:00 PM
BEEKMAN ROOM
SCIENTIFIC SESSION: 
Delivery Technologies in Cosmetics, Personal 
Care, and Household Products 
Moderated by: Alireza Abbaspourrad  
& Parizad Adil Elchidana 
Session Chair: Tapashi Sengupta
SUTTON NORTH
SCIENTIFIC SESSION: 
Micro- and Nanoparticle Delivery
Moderated by: Fakhrul Ahsan 
Session Chair: You Han Bae
SUTTON CENTER
FOCUS GROUP SCIENTIFIC SESSION: 
Bioinspired and Biomimetic Drug Delivery 
(BBDD) Focus Group Scientific Session
Session Chair: Zhen Gu 
Session Co-Chair: Zhuang Liu
3:00 PM  
I-1  Engineering Of Bioadhesive Nanoparticles 
To Produce Broad-spectrum, Non-
penetrating Sunscreens 
Mark Saltzman, Yale University, U.S.A.
3:30 PM  
I-2  Skin Penetration and Release - 
Overcoming Obstacles and Methods to 
confirm Targeted Delivery 
Peter Landa, Estee Lauder, U.S.A.
4:00 PM  
1  Ocular Diabetic Theranosis Using Smart 
Contact Lens 
S. Hahn, D. Keum; POSTECH, Pohang, 
Republic of Korea
4:10 PM  
2  Randomised, Split-Face Study Of The 
Efficacy Of Microneedle Patches With 
Accelerated Absorption Of Hyaluronic 
Acid For Reduction Of Static Lateral 
Canthus Rhytides 
N. De Mello1, R. Bamsey2; 1Swansea Univ., 
Swansea, United Kingdom, 2Innoture 
Limited, Swansea, United Kingdom
4:20 PM  
3  Localised Skin Delivery Of Cosmetic 
Actives And The Effect Of Formulation, 
Using Mass Spectrometry Imaging For 
Both In Vivo And Ex Vivo Sample Analysis 
N. Starr1, J. Hicks2, C. Elms2, M. Bell2, 
L. Pérez-García1, D. Scurr1; 1Univ. of 
Nottingham, Nottingham, United 
Kingdom, 2Walgreens Boots Alliance, 
Nottingham, United Kingdom
4:30 PM  
4  Comparison of Skin Delivery of 
methyl Amino Levulinic Acid following 
Pretreatment with Three Physical 
Penetration Enhancement Technologies 
H. Benson1, Y. Jhanker1, M. Mbano1, T. 
Prow2; 1Curtin Univ., Perth, Australia, 2Univ. 




  pH Transistor Nanoparticles for Cancer 
Imaging and Surgery 
Jinming Gao, UT Southwestern Texas, 
USA
3:30 PM 
I-3  Using Lipid Nanocapsules To Translate 
Promising Molecules Into Therapies For 
Central Nervous System Diseases 
Anne des Rieux, Univ Catholique de 
Louvain, Belgium
4:00 PM 
5  Specific Targeting Of The Inflamed 
Myocardium By Mesenchymal Stem Cells-
derived Nano-ghosts 
N. Letko Khait, M. Machluf; Technion - 
Israel Inst. of Technology, Haifa, Israel
4:10 PM 
6  Targeted Combination Therapy To Treat 
Breast Cancer 
S. Lee, B. Law, M. Han, C-H. Tung; Weill 
Cornell Med., New York, NY, U.S.A.
4:20 PM 
7  The Development And Evaluation Of 
Novel Radiolabeled Niosomes As A 
Potential Passive Targeting Nanocarriers In 
Breast Cancer Murine Xenografts. 
L. De Silva1, L-H. Chuah1, T-T. Htar1, 
J-Y. Fu2, A. Kasbollah3, S. Muniyandy4; 
1Monash Univ. Malaysia, Subang Jaya, 
Malaysia, 2Malaysian Palm Oil Board, 
Bandar Baru Bangi, Malaysia, 3Malaysian 
Nuclear Agency, Kajang, Malaysia, 4Fatima 
Coll. of Hlth.Sci., Ajman, United Arab 
Emirates
4:30 PM 
8  Effect Of Temperature Elevation On 
Short Duration Focused Ultrasound 
Hyperthermia Mediated Drug Delivery 
Using Thermosensitive Liposomes And In 
Vivo Two-photon Microscopy 
M. A. Santos, D. E. Goertz, K. Hynynen; 
Univ. of Toronto, Toronto, ON, Canada
4:40 PM 
  Panel Discussion
3:00 PM 
  Bioinspired and Biomimetic Strategies for 
Drug Delivery 
Samir Mitragori, Harvard University, 
U.S.A.
3:30 PM 
218  Synthetic Cells Produce Protein Medicines 
Inside Tumors 
A. Schroeder; Technion - Israel Inst. of 
Technology, Haifa, Israel 
BBDD Focus Group Young Investigator 
Award Winner
3:55 PM 
265  Bacteria-inspired Surface Modification 
With Polygammaglutamic Acid For 
Biocompatibility Of Nanomaterials 
G. Shim, D. Kim, J. Kim, M. Suh, Y-K. Oh; 
Seoul Natl. Univ., Seoul, Republic of Korea
4:15 PM 
14  Extracellular Vesicle-based Hydrogels As 
Efficient Machinery For Anti-inflammatory 
Therapeutics Synthesis 
G. Fuhrmann1, R. Chandrawati2, P. 
A. Pamar3, T. J. Keane3, S. Bertazzo4, 
M. M. Stevens3; 1Helmholtz-Inst. for 
Pharmaceutical Res., Saarbrücken, 
Germany, 2The Univ. of Sydney, Sydney, 
Australia, 3Imperial Coll., London, United 
Kingdom, 4Univ. Coll., London, United 
Kingdom
4:30 PM 
177  Polymeric Nanoparticles Encapsulating 
TLR7/8 Agonist For NK Cell-mediated 
Cancer Immunotherapy 
H. Kim, T. A. Kucaba, P. Larson, V. Khanna, 
D. M. Ferguson, T. S. Griffith, J. Panyam; 
Univ. of Minnesota, Minneapolis, MN, 
U.S.A.
4:45 PM 
613  Nature-inspired Peptide-based Virus 
Mimics For Plasmid DNA Delivery 
R. NI, Y. CHAU; Hong Kong Univ. of Sci. 
and Technology, Kowloon, Hong Kong














Sunday, July 22 | 3:00 PM – 5:00 PM (continued)
SUTTON SOUTH
FOCUS GROUP SCIENTIFIC SESSION: 
Gene Delivery and Gene Editing Focus Groups 
Scientific Sessions
Session Chair: Dan Siegwart 
Session Co-Chair: Gaurav Sahay
REGENT ROOM 
MINI-SYMPOSIUM: 
3D Printing in Drug Delivery
Session Co-chairs: Abu Serajuddin &  
Akm Khairuzzaman
GRAND BALLROOM
INDUSTRY ROUND TABLE: 
Delivering Meaningful Value to Rare Disease 
Patients through Innovation & Partnership
Moderated by: Patrick Lim Soo
3:00 PM 
  Nanoformulations for delivery of RNA and 
genome editing complexes 
Daniel Anderson, MIT, Boston, U.S.A.
3:30 PM 
  Cancer-specific And Biologically-informed 
Biomaterials for gene- and drug-delivery 
Natalie Artzi, Harvard Medical School, 
Boston, U.S.A. 
GDE Focus Group Young Investigator 
Award Winner
3:50 PM 
10  Nonviral Genome Editing Via CRISPR/cas9 
Delivery By Membrane-disruptive And 
Endosomolytic Helical Polypeptide 
H-X. Wang1, Z. Song2, Y-H. Lao1, J. Gong1, 
M. Li1, L. Yin3, J. Cheng2, K. W. Leong1; 
1Columbia Univ., New York, NY, 2Univ. of 
Illinois at Urbana-Champaign, Champaign, 
IL, 3Soochow Univ., Suzhou, China
4:10 PM 
594  Pre-Treatment Of Brain Tissue With 
Pulsed Focused Ultrasound Enhances 
Brain-penetrating Nanoparticle-Mediated 
Transfection Via Mechanosensitive TRPA1 
Channel Activation 
B. Mead1, C. Curley1, N. Kim2, J. Song1, 
G. Miller1, W. Garrison1, J. W. Mandell1, 
A. Klibanov1, J. Suk2, J. Hanes2, R. J. 
Price1; 1Univ. of Virginia, Charlottesville, 
VA, 2Johns Hopkins Univ., Baltimore, MD, 
U.S.A.
4:20 PM 
598  In Vivo Bone Marrow Nucleic Acid Delivery 
Systems for Therapeutic Targeting of 
Multiple Myeloma-Microenvironment 
Interactions 
M. J. Mitchell; Univ. of Pennsylvania, 
Philadelphia, PA, U.S.A.
4:30 PM 
600  Lipid Nanoparticle Ionization At 
Endosomal pH Is A Cell-free Predictor Of 
mRNA Delivery Efficacy In Vivo 
K. A. Hajj, K. A. Whitehead; Carnegie 
Mellon Univ., Pittsburgh, PA, U.S.A.
4:40 PM 
645  Development Of Polymeric Micelles For 
mRNA Delivery Through Complexation 
With Flexible Block Ionomers 
T. Miyazaki, S. Uchida, H. Cabral; The 
Univ. of Tokyo, Tokyo, Japan
4:50 PM 
595  Immunogene Therapy of Infections Using 
Fusogenic Porous Silicon Nanoparticles 
B. Kim; Univ. of California, San Diego, La 
Jolla, CA, U.S.A.
3:00 PM 
  Formulation of 3D-printed tablets 
Abu Serajuddin 
St. John’s University, U.S.A.
3:30 PM 
  3D-printed drug products 
Akm Khairuzzaman 
Food & Drug Administration Center for 
Drug Evaluation & Research, U.S.A.
4:00 PM 
  Challenges and directions of 3D-printed 
drug delivery 
Lifeng Kang 
University of Sydney, Australia
4:30 PM 
  Challenges and Directions of 3D-Printed 
Drug Delivery 




Executive Director, Medicinal Sciences at Pfizer
Manuel Sanchez-Felix 
Senior Fellow, Novel Delivery Technologies at 
Novartis
David H. Thompson 
Purdue University
Christian Girard 






















OPENING RECEPTION WITH EXHIBITORS 
5:00 PM – 7:00 PM | Rhinelander Gallery
PSAH NETWORKING EVENT* 
7:30 PM – 9:30 PM | Off-site Event (The Three Monkeys Bar)
YOUNG SCIENTIST NETWORKING EVENT* 
6:30 PM – 9:30 PM | Off-site Event (Tir-na-Nog)
*Ticket purchase required. Tickets can be purchased at 
registration while supplies last.
Monday, July 23 
Morning Program
FOCUS GROUP MEMBERSHIP MEETINGS 
7:00 AM – 8:00 AM
CRS is proud to announce the formation of five, new Focus 
Groups that are built on the concept of providing you 
opportunities that were not previously available to you 
including networking with field leaders, getting exposure 
for your research program, and becoming (and remaining) a 
vital part of your research community. All members of CRS 
who are interested in learning more about a specific focus 
group are invited to attend these membership meetings. 
Ocular Drug Delivery (OcDD) 
Bryant Room
Biomimetic and Bio Inspired Drug Delivery (BBDD) 
Morgan Room
Oral Drug Delivery (OrDD) 
Madison Room
Gene Delivery and Gene Editing (GDE) 
Clinton Room
Nanomedicine and Nanoscale Drug Delivery (NNDD) 
Nassau East
YOUNG SCIENTISTS START WITH A LUMINARY* 
7:00 AM – 8:00 AM | Nassau West
Throwback the sheets, gulp down some coffee and head to 
this early morning event that will provide young scientists 
an opportunity to get to know and network with luminaries 
in the CRS community. This session aims to inspire the next 
generation of young scientists by giving direct access to 
established scientists that are internationally recognized for 
outstanding contributions in the science and technology of 
controlled release and have promoted the advancement 
of the field. Questions about their story, how they got 
to where they are today, what they would do differently 
and what advice would they give to early career scientists 
today can all be answered in this informal and relaxed 
setting. Bring plenty of business cards and plan on starting 
connections that could last a lifetime.
Luminaries: Steven Schwendeman, Justin Hanes, 
Mark Saltzman & Molly Stevens
EXHIBIT HALL OPEN 
9:30 AM – 4:30 PM
PLENARY SESSION 2 
Moderated by: Twan Lammers, RWTH Aachen University, 
Germany 
Re-engineering the Tumor Microenvironment to 
Improve Cancer Treatment 
8:00 AM – 9:00 AM | Grand Ballroom
Rakesh Jain 
Harvard Medical School and Massachusetts 
General Hospital, U.S.A.
Pancreatic Cancer: A Survivor’s Journey 
9:00 AM – 9:30 AM | Grand Ballroom
Lora Kelly 
Central PA Chapter of the National 
Pancreas Foundation (NPF), U.S.A.
Followed by An Interactive Session with  
Rakesh Jain & Lora Kelly 
9:30 AM – 10:00 AM | Grand Ballroom 
At the end of the lecture, attendees can meet and greet 
with Rakesh Jain & Lora Kelly to ask questions related to the 
scope of the talk, the science discussed, career advice, etc. 
This will be done in an informal and interactive setting.
EXHIBIT HALL OPEN 
9:00 AM – 4:30 PM
REFRESHMENT BREAK 
9:30 AM – 10:00 AM | Rhinelander Gallery
CONCURRENT SESSIONS 
10:00 AM – 12:00 PM 
See pages 14 & 15 for details.
LUNCH IN EXHIBITION HALL 
12:00 PM – 1:30 PM
A complimentary boxed lunch will be served in the 
Exhibition Hall (Rhinelander Gallery)
C&DP Lunch Networking Event 
12:00 PM – 1:30 PM 
Sponsored by: 
CONCURRENT SESSIONS 
1:30 PM – 3:30 PM 
See pages 16 & 17 for details.
*Ticket purchase required. Tickets can be purchased at 

















Moderated by: Arash Hatefi 




Moderated By: Abraham Rubinstein 
Session Chair: Brian Amsden
BEEKMAN ROOM
MINI-SYMPOSIUM: 
Advanced Immunotherapy For Neuro-
Oncology
Session Chair: Julia Y. Ljubimova
10:00 AM 
I-5  Nucleic Acid Carrier Optimization By Bioinspired 
Chemical Evolution 
Ernst Wagner, Ludwig Maximilians Univ., 
Germany
10:30 AM 
I-6  Controlled Intracellular Trafficking and 
Selective Tissue Targeting by Multifunctional 
Envelope-type Nano Device for Nucleic Acid 
Nanomedicine 
Hideyoshi Harashima, Hokkaido Univ., Japan
11:00 AM 
9  Using Calcium Phosphate Lipid-Coated 
Nanoparticles to Deliver Antisense 
Oligonucleotides to Motor Neurons in 
Amyotrophic Lateral Sclerosis 
K. L. Vine1, C. Watson1, L. Chen1, M. Morsch2, N. 
J. Cole3, D. N. Saunders4, J. Yerbury1; 1Illawarra 
Hlth.and Med. Res. Inst., Univ. of Wollongong, 
Wollongong, Australia, 2Dept. of BioMed. Sci., 
Macquarie Univ., Sydney, Australia, 3Dept. of 
BioMed. Sci., Faculty of Med. and Hlth.Sci., 
Macquarie Univ., Sydney, Australia, 4Sch. of Med. 
Sci., Univ. of New South Wales, Sydney, Australia
11:10 AM 
10  Nonviral Genome Editing Via CRISPR/
cas9 Delivery By Membrane-disruptive And 
Endosomolytic Helical Polypeptide 
H-X. Wang1, Z. Song2, Y-H. Lao1, J. Gong1, M. Li1, L. 
Yin3, J. Cheng2, K. W. Leong1; 1Columbia Univ., New 
York, NY, 2Univ. of Illinois at Urbana-Champaign, 
Champaign, IL, 3Soochow Univ., Suzhou, China
11:20 AM 
11  Presaturating Kupffer Cells With Nanoprimers 
Improves Tumor Delivery of mRNA Nanoparticles 
In Vivo 
M. S. Paolini1, F. Mpambani2, M. Bergere2, O. S. 
Fenton1, A. K. Patel1, L. Poul2, R. S. Langer1, M. 
Germain2; 1MIT, Cambridge, MA, 2Nanobiotix, Paris, 
France
11:30 AM 
12  Lipid-polymer Hybrid Nanoparticles (LPNS) For 
Efficient Pulmonary Delivery Of Nucleic Acids: 
Lessons Learnt From Quality-by-design Based 
Optimization, Immunogenicity Studies, In Vitro 
Release Experiments, In Vivo Biodistribution And 
Efficacy Studies 
K. Thanki1, A. Thakur1, A. M. d. Groot2, A. 
Geyer3, J. Fraire4, E. Falkenberg1, H. V. Eygen1, E. 
Putteman1, D. C. v. Bijnen2, X. Zeng1, H. Sami3, S. 
Gehrig3, S. Justesen1, H. Franzyk1, F. Broere2, W. 
v. Eden2, A. J. Sijts2, M. Ogris3, H. M. Nielsen1, K. 
Braeckmans4, C. Foged1; 1Univ. of Copenhagen, 
Copenhagen, Denmark, 2Utrecht Univ., Utrecht, 
Netherlands, 3Univ. of Vienna, Vienna, Austria, 
4Ghent Univ., Ghent, Belgium
11:40 AM 
  Panel Discussion
10:00 AM 
I-7  Local Drug Delivery 
Daniel Kohane, Boston Children’s 
Hospital, U.S.A.
10:30 AM 
I-8  Cancer-specific And Biologically-
informed Biomaterials 
Natalie Artzi, Brigham and Women’s 
Hospital, Harvard Medical School, 
U.S.A.
11:00 AM 
13  Leveraging Decreased Non-specific 
Adhesivity, Receptor-targeted (dart) 
Nanoparticles For Treatment Of 
Invasive Brain Tumors 
A. Wadajkar1, J. Dancy1, N. Connolly1, 
N. Gorelick2, B. Tyler2, J. Winkles1, 
G. Woodworth1, A. Kim1; 1Univ. of 
Maryland Sch. of Med., Baltimore, MD, 
2Johns Hopkins Univ. Sch. of Med., 
Baltimore, MD, U.S.A.
11:10 AM 
14  Extracellular Vesicle-based Hydrogels 
As Efficient Machinery For Anti-
inflammatory Therapeutics Synthesis 
G. Fuhrmann1, R. Chandrawati2, P. 
A. Pamar3, T. J. Keane3, S. Bertazzo4, 
M. M. Stevens3; 1Helmholtz-Inst. for 
Pharmaceutical Res., Saarbrücken, 
Germany, 2The Univ. of Sydney, 
Sydney, Australia, 3Imperial Coll., 
London, United Kingdom, 4Univ. Coll., 
London, United Kingdom
11:20 AM 
15  Ocular Pharmacokinetics Of A 
Dexamethasone-eluting Contact Lens 
J. B. Ciolino1, B. Salvador-Culla1, L. 
C. Bengani2, R. Tulsan2, A. E. Ross2, 
D. S. Kohane3; 1Massachusetts Eye 
& Ear/Harvard Med. Sch., Boston, 
MA, 2Schepens Eye Res. Inst. at 
Massachusettes Eye & Ear/Harvard 
Med. Sch., Boston, MA, 3Boston 
Children’s Hosp./Harvard Med. Sch., 
Boston, MA
11:30 AM 
16  Electrospun Composite Scaffolds For 
Controlled Release Of The Bioactive 
Lipid, Siponimod To Augment Bone 
Regeneration 
Z. Sartawi, C. Waeber, K. Ryan; Univ. 
Coll. Cork, Cork, Ireland
11:40 AM 
  Panel Discussion
10:00 AM 
I-9  Harnessing the host-immune system 
for glioma therapeutics: Impact of the 
tumor genotype 
Maria Graciela Castro, University of 
Michigan, U.S.A.
10:30 AM 
I-10  Superparamagnetic Iron oxide 
nanoparticles (SPIONs) for magnetic 
resonance imaging of macrophagesin 
gliomas: at the interface between 
nanomedicine and innate immunity 
Dmitri Simberg, University of 
Colorado, U.S.A.
11:00 AM 
I-11  Nano immunology approach for the 
treatment of brain tumors: importance 
of brain local immune system 
activation 
Julia Y. Ljubimova, Cedars-Sinai 
Medical Center, U.S.A.
11:30 AM 
I-12  Cancer Nanotechnology – Current 
Status and Emerging Opportunities 














Monday July 23 | 1:30 PM-3:30 PM
SUTTON NORTH
INDUSTRY ROUNDTABLE: 
Inflection Point of Drug Formulation: 
Advanced in Silico Applications for 
Rational Drug Development




Interactive Session with the World 
Molecular Imaging Society: Combining 
imaging and targeted drug delivery to 
create clinical impact




Oral Delivery for Food and Pharma
Moderated By: Venkatta Yelleppedi  
Session Chair: Ben Boyd
Sponsored by:
Simulation and Modeling Drug-Polymer 
Interaction and Drug Transport/
Release through Excipient Polymer Gels 
presented by Ronald G. Larson 
Department of Chemical Engineering, 
University of Michigan
Integrated pharmacokinetic modelling to 




Case Western Reserve University, U.S.A.
Jan Grimm 
Memorial Sloan Kettering Cancer Center, 
U.S.A.
Fabian Kiessling 
RWTH Aachen University, Germany
Thomas Reiner 
Memorial Sloan Kettering Cancer Center, 
U.S.A.
1:30 PM 
I-13  Specific High Uptake And Systemic Transport Of 
Nanoparticles At The Distal Ileum By Oral Dosing 
You Han Bae, University of Utah, U.S.A.
2:00 PM 
I-14  Oral Peptide Delivery: The Potential Of Combining 
Nanoparticle Constructs With Permeation Enhancers 
David Brayden, University of College Dublin, Ireland
2:30 PM 
I-15  Controlling The Release From Bioresponsive Platforms 
Alirezza Abbaspourrad, Cornell University, U.S.A.
3:00 PM 
17  Multifunctional Nanoparticles Enable Efficient 
Oral Delivery of Biomacromolecules via Altering 
Transcytosis Pathway 
Y. Zheng, Y. Huang; Sichuan Univ., Chengdu, China














Monday July 23 | 1:30 PM-3:30 PM (continued)
REGENT ROOM
MINI-SYMPOSIUM: 
Digitally Controlled Drug Delivery
SUTTON CENTER
FOCUS GROUP SCIENTIFIC SESSION: 
Ocular Drug Delivery (OcDD)
Session Chair: Morgan Fedorchak 
Session Co-Chair: Thakur Raghu Raj Singh
GRAND BALLROOM
FOCUS GROUP SCIENTIFIC SESSION: 
Nanomedicine and Nanoscale Drug Delivery 
(NNDD)
Session Chair: Bruno Sarmento 
Session Co-Chair: Helena Florindo
1:30 PM 
Smart soft lens for diagnosis and delivery 
Sei Kwang Hahn 
Department of Materials Science and 
Engineering, POSTECH, Republic of Korea
2:00 PM 
Smart bandage for precise dose control 
Ali Tamayol 
University of Nebraska-Lincoln, U.S.A.
2:30 PM 





An ingestible bacterial-electronic system to 
monitor gastrointestinal health 
Mark Kyle Mimee,  
Research Laboratory of Electronics, U.S.A.
1:30 PM 
  Complex Drug Products for Ocular 
Delivery 
Uday Kompella, University of Colorado, U.S.A.
2:00 PM 
28  Mucoadhesive Micelles For The Treatment 
Of Ocular Conditions 
F. Lasowski, B. Muirhead, T. Rambarran, 
H. Sheardown; McMaster Univ., Hamilton, 
ON, Canada
2:20 PM 
306  Gelatinized Core Liposomes: A New 
Trojan Horse For The Development Of A 
Novel Glaucoma Medication 
R. M. Hathout, H. A. Gad, S. M. Abdel-
Hafez, N. Nasser, N. Khalil, T. Ateyya, A. 
Amr, N. Yasser, S. Nasr, A. A. Metwally; 
Faculty of Pharmacy - Ain Shams Univ., 
Cairo, Egypt
2:34 PM 
230  Investigation Of The Impacts Of 
Pegylation On The Intraocular Distribution 
Of The Intravitreal Nanocarriers. 
X. HUANG, Y. CHAU; Hong Kong Univ. 
of Sci. and Technology, Hong Kong, Hong 
Kong
2:48 PM 
57  Laser-Assisted Microportaion to Enhance 
Ocular Drug Delivery 
R. Singh1, S. Adwan2, R. Donnelly1; 
1Queens Univ. Belfast, Belfast, United 
Kingdom, 22Sch. of Pharmacy, Zarqa Univ., 
Zarqa, Jordan
3:02 PM 
656  A Modified Hyaluronic Acid Based 
Instillable Hydrogel For The Treatment Of 
Dry Eye Syndrome In Dog Patients 
Y. Yu1, D. Chow2, Y. Chau1; 1The Hong 
Kong Univ. of Sci. and Technology, Hong 
Kong, China, 2Vet. Specialty Hosp., Hong 
Kong, China
3:16 PM 
551  Evaluation Of Antifibrotic Drug 
Nanowafers To Prevent Corneal Scarring 
C. S. Shin, M. Zaheer, A. Zhu, R. Lee, J. 
Kim, G. Acharya; Baylor Coll. of Med., 
Houston, TX
1:30 PM 
I-16  A Molecular Platform for RNA 
Therapeutics 
Dan Peer, Tel Aviv University, Israel
2:00 PM 
260  Machine Learning Processes to Develop 
Targeted Nanomedicines 
D. A. Heller, Y. Shamay, J. Shah, M. Isik, J. 
D. Chodera; Mem. Sloan Kettering Cancer 
Ctr., New York, NY 
NNDD Focus Group Young Scientist 
Awardee
2:20 PM 
223  Orally Delivered Butyrate-functionalized 
Nanovehicles To Overcome Multiple 
Barriers And Insight Into “Easy Entry, 
Hard Exit” Of Active Targeting System In 
Intestinal Absorption 
L. Wu, Y. Huang; Sichuan Univ., Chengdu, 
China
2:40 PM 
225  Multicellular Spheroids As Novel Tools 
For The Evaluation Of Melanoma 
Nano-vaccines And Braf-mek-targeted 
Nanomedicines. 
A. Scomparin1, S. Pozzi1, E. Yeini1, J. 
Conniot2, S. Koshrovski1, E. Pisarevsky1, 
H. Florindo2, R. Satchi-Fainaro1; 1Tel Aviv 
Univ., Tel Aviv, Israel, 2Univ. of Lisbon, 
Lisbon, Portugal
2:52 PM 
226  Biodegradable Polymalic Acid Conjugated 
To Angiopep-2 And Tri-leucine Traverses 
The Blood-brain-barrier And Distributes 
Throughout The Mouse Brain 
L. L. Israel, O. Braubach, A. Galstyan, A. 
Chiechi, E. Shatalova, Z. Grodzinski, H. 
Ding, K. L. Black, J. Ljubimova, E. Holler; 
Cedars Sinai Med. center, Los Angeles, CA
3:04 PM 
255  Tumor Penetration Promoting Polymeric 
Micelles Stabilized By π-π Stacking 
X. Bai1, G. Storm2, W. Hennink2, F. 
Kisseling1, T.Lammers1, Y. Shi1; 1RWTH 
Aachen Univ. Clinic, Aachen, Germany, 
2Utrecht Univ., Utrecht, Netherlands
3:16 PM 
433  Nanoparticle-based Vaginal Combination 
Therapy For The Prevention Of 
Inflammation-induced Preterm Birth 
H. Zierden1, J. Ortiz Ortiz1, S. Bensouda1, 
V. Laney1, Y. Zou2, J. Maziarz2, J. Hanes1, 
M. Mahendroo3, G. Wagner2, L. Ensign1; 
1Johns Hopkins Univ., Baltimore, MD, 













Monday July 23 (continued)
REFRESHMENT BREAK 
3:30 PM – 4:00 PM | Rhinelander Gallery
PEARLS OF WISDOM 
Targeted Nano-Drugs 
4:00 PM – 5:00 PM | Grand Ballroom
In this session, two world-leading scientists will present 
different views and discuss controversies in the targeted 
nanomedicine field. The session will start with two short 
presentations, followed by 15 minutes of 1-on-1 discussion 
and 15 minutes of interactive discussion with the audience. 
Please make sure to join us for the memorable event.
Moderated by: Twan Lammers, RWTH Aachen University, 
Germany
“Should we be Disappointed?” 
Gert Storm, Utrecht University, Netherlands
“Can we be Optimistic?” 
Warren Chan, University of Toronto, Canada
POSTER PUB 
5:00 PM – 6:00 PM | Rhinelander Gallery
Grab a drink and some face-time with poster presentations 
at this year’s Poster Pub. The exhibit hall will be open at 
this time.
WOMEN IN SCIENCE NETWORKING EVENT* 
6:00 PM – 7:00 PM | Regent Room
Honoring Molly Stevens 
Imperial College London, U.K.
Focus Group Social Event 
8:30 PM – 10:00 PM | Beekman Room
*Ticket purchase required. Tickets can be purchased at 
registration while supplies last.
Tuesday, July 24 
Morning Programming
PLENARY SESSION 3 
Moderated by: Christine Allen, University of Toronto, 
Canada 
I-17 Exploring and Engineering the Cell-material 
Interface for Drug Delivery 
8:30 AM – 9:30 AM | Grand Ballroom
Molly Stevens 
Imperial College London, U.K.
Followed by An Interactive Session with Molly Stevens 
9:30 AM – 10:00 AM | Grand Ballroom 
At the end of the plenary lecture, attendees can meet 
and greet with Molly Stevens to ask questions related 
to the scope of the talk, the science discussed, career 
advice, etc. This will be done in an informal and 
interactive setting.
REFRESHMENT BREAK 
9:30 AM – 10:00 AM | Rhinelander Gallery
CONCURRENT SESSIONS 
10:00 AM – 12:00 PM 
See pages 19 & 20 for details.
LUNCH ON OWN 
12:00 PM – 1:30 PM
CONCURRENT SESSIONS 
1:30 PM – 3:30 PM 























Tuesday, July 24 | 10:00 AM – 12:00 PM
BEEKMAN
SCIENTIFIC SESSION: 
Tropical and Transdermal Delivery
Moderated By: Ying Chau & Bozena Michniak-Kohl 
Session Chair: Mark Prausnitz
SUTTON NORTH
SCIENTIFIC SESSION: 
Delivery of Proteins, Peptides and Vaccines
Moderated By: James Moon & Steven P. 
Schwendeman 
Session Chair: Tapashi Sengupta
SUTTON CENTER
SCIENTIFIC SESSION: 
Encapsulation for Industrial Applications
Moderated by: Yvonne Perrie
Session Chair: Cornell Stamorman
10:00 AM 
I-18  Controlled Transdermal Drug Delivery 
based on Onboard Wearable Biosensors 
Dae-Hyeong Kim, Seoul National 
University, Seoul, Republic of Korea
10:30 AM 
I-19  Glucose-Responsive Smart Insulin Patch 
Zhen Gu, University of North Carolina at 
Chapel Hill, U.S.A.
11:00 AM 
18  Microneedle Patches for Transdermal 
Antibiotic Delivery: Potential to Overcome 
Resistance. 
R. Donnelly; Queen’s Univ. Belfast, 
Belfast, United Kingdom
11:10 AM 
19  pH-sensitive Vancomycin Nanofibers for 
Localized Antimicrobial Applications: In 
Vitro And In Vivo Assessments 
L. M. Abdel Rahman1, H. M. M. Eltaher2, 
K. Abdel-Raouf3, M. Bahey El-Din2, C. 
Ismail2, E. S. Kenawy4, L. K. El-Khordagui2; 
1Alexandria Pharmaceutical Company, 
Alexandria, Egypt, 2Alexandria Univ., 
Alexandria, Egypt, 3Hartford Hosp., 
Hartford, CT, 4Tanta Univ., Tanta, Egypt
11:20 AM 
20  Investigation Of The Permeation Of 
Solid Lipid Nanoparticles Loaded With 
Ketoconazole Into Skin Layers Using 
Spectroscopic Imaging Techniques 
s. Gourion-Arsiquaud1, S. Trehan2, K. 
Wyluda1, Q. Zhang1, B. Michniak-Kohn2, 
I. Pal Kaur3; 1TRI Princeton, Princeton, 
NJ, 2Ctr. for Dermal Res., Rutgers 
Univ., Piscataway, NJ, 3Univ. Inst. of 
Pharmaceutical Sci., Chandigarh, India
11:30 AM 
21  Living Bacteria in Thermo-Responsive Gel 
For Treating Fungal Infections 
M. Luton, E. Corem-Salkmon, B. Mizrahi; 
Technion, Haifa, Israel
11:40 AM 
  Panel Discussion
10:00 AM 
I-20  Engineering Macrophage-derived 
Exosomes For Targeted Paclitaxel Delivery 
To Cancer Cells 
Elena Batrakova, University of North 
Carolina at Chapel Hill, U.S.A.
10:30 AM 
I-21  The Power Of Chemoselectivy: Functional 
Antibody-conjugates For Extra- And 
Intracellular Targeting 
Christian Hackengerger, Leibniz-
Forschungsinstitut fur Molekulare 
Pharmakologie, Berlin, Germany
11:00 AM 
22  Polymeric Nanoparticles By Inverse Flash 
NanoPrecipitation: Formulation Design To 
Modify Release Of Biologics 
C. E. Markwalter, R. F. Pagels, R. K. 
Prud’homme; Princeton Univ., Princeton, 
NJ, U.S.A.
11:10 AM 
23  Dendritic Cell-targeted Nano-vaccines 
Synergize With Immune Checkpoint 
Modulators For Melanoma Treatment 
J. Conniot1, A. Scomparin2, C. Peres1, E. 
Yeini2, S. Pozzi2, E. Zupancic3, S. Jung3, R. 
Satchi-Fainaro2, H. F. Florindo1; 1Faculty 
of Pharmacy, Univ. of Lisbon, Lisbon, 
Portugal, 2Dept. of Physiology and 
Pharmacology, Sackler Faculty of Med., 
Tel Aviv Univ., Tel Aviv, Israel, 3Dept. of 
Immunology, The Weizmann Inst. of Sci., 
Rehovot, Israel
11:20 AM 
24  Calcitriol peptide Liposomes Supress 
Antigen specific Autoreactive T Cell 
Expansion And Memory Differentiation To 
Regulate Autoimmune Arthritis 
M. Talekar; Univ. of Queensland, 4102, 
Australia
11:30 AM 
25  Subcutaneous Elastin-like Polypeptides 
(ELP) Loaded With Rapamycin Alleviate 
Dacryoadenitis In A Model Of Sjögren’s 
Syndrome 
C. Lee1, H. Guo1, W. Klinngam1, S. Janga2, 
F. Yarber2, M. Edman2, S. Peddi1, S. F. 
Hamm-Alvarez2, J. A. MacKay1; 1Dept. 
of Pharmacology and Pharmaceutical 
Sci., Sch. of Pharmacy, Univ. of Southern 
California, Los Angeles, CA, 2Dept. of 
Ophthalmology, Roski Eye Inst. and Keck 
Sch. of Med., Univ. of Southern California, 
Los Angeles, CA
11:40 AM 
  Panel Discussion
10:00 AM 
I-22  A Novel, Continuous Microencapsulation 
Process for Industrial Applications 
Steve Thomas, Cambridge Consultants, 
United Kingdom
10:30 AM 
26  Effect Of Encapsulation Of DNA On 
Lipidic Cubic Phase 
S. Sarkar; RMIT, Melbourne, Australia
10:40 AM 
27  Systemic Study of Solvent-assisted 
Active Loading of Gambogic Acid 
Into Liposomes and Its Formulation 
Optimization for Improved Delivery 
W-L. Tang, S-D. Li; Univ. of British 
Columbia, Vancouver, BC, Canada
10:50 AM 
28  Mucoadhesive Micelles For The Treatment 
Of Ocular Conditions 
F. Lasowski, B. Muirhead, T. Rambarran, 
H. Sheardown; McMaster Univ., Hamilton, 
ON, Canada
11:00 AM 
29  Stabilization Of Bioinspired Non-spherical 
Cell Membrane-coated Nanoparticles By 
Lyophilization 
B. M. Haryadi; Ludwig-Maximilians-Univ. 
München, Munich, Germany
11:10 AM 
30  Single-dose Azithromycin-loaded 
Nanoparticles-in-nanofibers Insert As A 
Therapy For Ocular Bacterial Infection 
I. Khalil1, I. G. Ali2, I. M. El-Sherbiny3; 
1Misr Univ. for Sci. and Technology, 
Roxbury, MA, 2Nanomaterials Lab, Ctr. of 
Material Sci. (CMS), Zewail City of Sci. and 
Technology, Cairo, Egypt, 3Nanomaterials 
Lab., Ctr. of Material Sci. (CMS), Zewail 
City of Sci. and Technology, Cairo, Egypt
11:20 AM 
31  The Effect Of Processing Conditions On 
The Loading And Release From PLGA 
Microparticles 
A. Otte1, B. Soh2, G. Yoon2, K. Park1; 
1Purdue Univ., West Lafayette, IN, 2Chong 
Kun Dang Pharmaceutical/Purdue Univ., 
West Lafayette, IN, U.S.A.
11:30 AM 
32  BAR-Encapsulated And BAR-Modified 
Nanoparticles For Oral Biofilm 
Applications 
M. Y. Mahmoud, D. R. Demuth, J. M. 
Steinbach-Rankins; Univ. of Louisville, 
Louisville, KY, U.S.A.
11:40 AM 
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Tuesday, July 24 | 10:00 AM – 12:00 PM (continued)
SUTTON SOUTH
SPECIAL SESSION: 
Toward an Improved Understanding of 
Complex Drug Substances and Complex 
Formulations Through GDUFA Regulatory 
Research Program




Polymer Therapeutics Clinical Translation: 
Challenges and Opportunities





Session Co-Chairs: Shawn C. Owen &  
Dhaval K. Shah
10:00 AM 
  Challenges and Opportunities for 
Innovation in Complex Generic Drug 
Product Development 
Xiaohui (Jeff) Jiang, U.S. FDA, CDER, 
Office of Generic Drugs, U.S.A.
10:25 AM 
  Development of Generic Long Acting 
Injectable and Implantable Drug Products: 
Regulatory Challenges and Considerations 
Yan Wang,  U.S. FDA, CDER, Office of 
Generic Drugs, U.S.A.
10:55 AM 
  Dissecting Drug Release from Emulsions: 
A Balance Between Kinetics and 
Equilibrium 
Xiaoming Xu, U.S., FDA, CDER, Office of 
Pharmaceutical Quality, USA
 Followed by a roundtable discussion.
10:00 AM 
I-23  Reverting Cancer’s Poor Prognosis Using 
Precision Nanomedicines Based On 
Molecular Fingerprints Of Long-term 




I-24  Reverting Cancer’s Poor Prognosis Using 
Precision Nanomedicines Based On 
Molecular Fingerprints Of Long-term 
Versus Short-term Survivors 
Ronit Satchi-Fainaro 
Tel Aviv University, Israel
10:40 AM 
I-25  Polymeric Micelles at the Clinical Stage 
Alexander Kabanov 
UNCH University of North Carolina Chapel 
Hill, U.S.A.
11:00 AM 
I-26  Control Architecture And Supramolecular 
Assembly In Polypeptide-based Conjugates 
Maria Vicent 
CIPF Centro de Investigación Príncipe 
Felipe, Spain
11:20 AM 
I-27  Clinical Challenges towards Next 
Generation Polymeric Nanomedicines 
Horacio Cabral 
University of Tokyo, Japan
10:00 AM 
  Strategies to Potentiate Antibody Drug 
Conjugates 
Shawn C. Owen 
University of Utah
10:20 AM 
  Role of PK/PD in ADC Development 
Dhaval K. Shah 
University at Buffalo, U.S.A.
10:40 AM 
I-28  Application of the ClassicDiels-Alder 
Reaction for Production of Antibody-Drug 
Conjugates 
R. James Christie 
Medimmune, U.S.A.
11:00 AM 





  Drugging intractable targets with 
antibodies 
David A. Scheinberg 
Memorial Sloan Kettering Cancer Center, 
U.S.A.

















Moderated By: Anna Schwendeman 
Session Chair: Diane Burgess
SUTTON NORTH
SCIENTIFIC SESSION: 
Manufacture, Characterization, Measurement, 
and Stability
Moderated By: Richard A. Gemeinhart 
Session Chair: Ali Rajabi-Siahboomi
REGENT ROOM
MINI-SYMPOSIUM: 
Cells as Delivery Vehicles
Session Co-chairs: Jana Portnow &  
Zhenjia Wang
1:30 PM 
I-30  Engineering Microneedles For 
Stimulating and Sampling Immunity 
Darrell Irvine, MIT, U.S.A
2:00 PM 
I-31  Targeting inflammation and immune 
dysregulation in neonatal and 
pediatric CNS disorders 
Sujatha Kannan, John Hopkins 
University. U.S.A.
2:30 PM 
33  Harnessing Fibroblast Growth Factor-
indicible 14 (fn14) For Targeting 
Metastatic Triple Negative Breast 
Cancer 
J. G. Dancy, A. S. Wadajkar, G. 
F. Woodworth, J. A. Winkles, A. J. 
Kim; Univ. of Maryland Sch. of Med., 
Baltimore, MD
2:40 PM 
34  Computationally-designed 
Nanotherapeutics For Targeting 
Immunosuppressive Cells In The 
Tumor 
A. Kulkarni1, S. Natarajan2, V. 
Chandrasekar2, S. Sengupta2; 1Univ. 
of Massachusetts Amherst, Amherst, 
MA, 2Brigham and Women’s Hosp., 
Cambridge, MA
2:50 PM 
35  Controlled Drug Releasing System 
Using Biodegradable Temperature-
responsive Injectable Polymers 
Containing Liposome 
Y. Yoshizaki1, H. Yamamoto2, A. 
Kuzuya3, Y. Ohya3; 1ORDIST, Kansai 
Univ., Osaka, Japan, 2Faculty 
of Chemistry, Materials and 
Bioengineering, Kansai Univ., Osaka, 
Japan, 3CEMP, Kansai Univ., Osaka, 
Japan
3:00 PM 
36  Long Acting Injectable Suspension 
with High Drug Load Aided by 
Inorganic Nanoshells 
J. Hellrup, E. Mårtensson, A. 
Johansson, M. Rooth; Nanexa AB, 
Uppsala, Sweden
3:10 PM 
  Panel Discussion
1:30 PM 
I-32  Nanostructured Carriers For Controlled Release - 
Characterization And Stability 
Maria Lundin Johnson, Research Institutes of 
Sweden, Sweden
2:00 PM 
37  Design And Physicochemical Characterization Of 
Fenofibrate Solid Dispersion By Supercritical Anti-
solvent Process 
J. Ahn, S-E. Lee, J-S. Park, K-S. Heo, C-S. 
Myung; Chungnam Natl. Univ., Daejeon, 
Republic of Korea
2:10 PM 
38  Dispersibility Of Phospholipids In Supercritical 
Carbon Dioxide For Preparation Of Liposomes 
F. Maqbool, P. M. Moyle, J. R. Falconer; 
The Univ. of Queensland, Brisbane Australia, 
Brisbane, Australia
2:20 PM 
39  Radiolabeling Of Cell Membrane-Based 
Nano-Carriers Facilitates Robust And Sensitive 
Quantification Of Their Biodistribution And 
Pharmacokinetics 
N. Letko Khait, M. Machluf; Technion - Israel 
Inst. of Technology, Haifa, Israel
2:30 PM 
40  Fabrication And Physico chemical 
Characterization Of Biodegradable Intra ocular 
Implant Of Budesonide 
F. Abedin Dorkoosh; Tehran Univ. of Med. Sci., 
Tehran, Islamic Republic of Iran
2:40 PM 
41  Thermal Analysis By Structural Characterisation 
(TASC) As A Novel Preformulation Tool For 
Drug-polymer Miscibility Screening 
M. Alhijjaj1, P. Belton2, L. Fabian1, N. Wellner3, 
M. Reading4, S. Qi1; 1Sch. of Pharmacy / Univ. 
of East Anglia, Norwich, United Kingdom, 2Sch. 
of Chemistry / Univ. of East Anglia, Norwich, 
United Kingdom, 3Quadram Inst. BioSci., 
Norwich Res. Park, Norwich, United Kingdom, 
4Cyversa, Norwich, United Kingdom
2:50 PM 
42  Advanced Fluorescent pH-Sensitive PLGA 
Particles for Controlled Targeted Therapeutic 
Delivery and Mapping Microenvironmental 
Biochemical Parameters 
V. M. Chauhan, M. Al-Natour, A. A. Selo, D. J. 
Scurr, R. Markus, C. Alexander, J. W. Aylott; Univ. 
of Nottingham, Nottingham, United Kingdom
3:00 PM 
43  Very Large Scale Droplet Microfluidic 
Integration For Industrial Scale Production Of 
Biodegradable Microparticles. 
S. Yadavali; Univ. of Pennsylvania, Philadelphia, PA
3:10 PM 
  Panel Discussion
1:30 PM 
Neural stem cells as delivery vehicles 
Jana Portnow, City of Hope National Medical 
Center, U.S.A.
2:00 PM 
Neutrophils for drug delivery to inflammation 
and infection  
Zhenjia Wang, Washington State University, 
U.S.A.
2:30 PM 
Red blood cells for delivery of drugs, 
biologicals, and nanoparticles 
Vladimir Muzykantov, Department of Systems 
Pharmacology and Translational Therapeutics, 
U.S.A.
3:00 PM 
Remotely controlled red blood cells for cancer 
targeted delivery 
Zhuang Liu, Institute of Functional Nano & 
Soft Materials (FUNSOM), The Jiangsu Key 
Laboratory for Carbon-Based Functional 












Tuesday July 24 | 1:30 PM – 3:30 PM (continued)
SUTTON CENTER
SPECIAL SESSION: 
Implant Formulation Optimization and In Vivo 
Performance
Moderated by: Thierry Vandamme
GRAND BALL ROOM
SPECIAL SESSION: 
CRS 45th Anniversary Celebration
Moderated by: Mark Prausnitz
SUTTON SOUTH
FOCUS GROUP SCIENTIFIC SESSION 
Oral Drug Delivery (OrDD)
Session Chair: Katie Whitehead 
Session Co-Chair: Aaron Anselmo
Diane Burgess 
University of Connecticut, U.S.A.
Long acting injections and implants improve 
therapy, enhance patient compliance, improve 
dosing convenience, and are the most 
appropriate formulation choice for drugs that 
undergo extensive first pass metabolism or that 
exhibit poor oral bioavailability. An intriguing 
variety of technologies have been developed 
to provide long acting injections and implants. 
Many considerations need to go into the 
design of these systems in order to translate a 
concept from the lab bench to actual therapy 
for a patient. Implants formulation optimization 
will be discussed and illustrated with in vitro 
and in vivo performance as well as performance 
testing.
This year, the Controlled Release Society 
is hosting its 45th Annual Meeting and are 
celebrating by taking a look at the past - 
present - and future of CRS.
1:40 PM 
Nicholas Peppas 
Former CRS President 1987-1988
2:10 PM 
Ron Siegel 
Former CRS President 1997-1998
2:30 PM 
Diane Burgess 
Former CRS President 2009-2010
2:50 PM 
Martyn Davies 
Former CRS President 2011-2012
3:05 PM 
Panel discussion on the status of Controlled 
Release Science and CRS activities in the future. 
Moderated by Maria Jose Alonso
1:30 PM 
I-33  Overcoming Barriers to Oral Protein 
Delivery 
Randall Mrsny, University of Bath, United 
Kingdom
2:00 PM 
32  BAR-Encapsulated And BAR-Modified 
Nanoparticles For Oral Biofilm 
Applications 
M. Y. Mahmoud, D. R. Demuth, J. M. 
Steinbach-Rankins; Univ. of Louisville, 
Louisville, KY 
OrDD Focus Group Young Investigator 
Award Winner
2:25 PM 
455  Development Of A Microstructured In 
Vitro 3D Model Of The Small Intestine 
Epithelium Using Poly(ethylene) Glycol 
Diacrylate Scaffolds 
M. García-Díaz, A. G. Castaño, N. Torras, 
G. Altay, E. Martínez; IBEC - Inst. for 
Bioengineering of Catalonia, Barcelona, 
Spain
2:45 PM 
459  Oral Permeability And Pharmacokinetics 
Of A Pediatric Formulation For The 
Treatment Of Cerebral Palsy 
V. K. Yellepeddi1, R. Mohammadipur1, C. 
Sayre2, S. Khambampati3, M. Mishra3, R. 
Kannan3, H. Ghandehari1; 1Univ. of Utah, 
Salt Lake City, UT, 2Roseman Univ. of Hlth.
Sci., Salt Lake City, UT, 3Johns Hopkins 
Univ., Baltimore, MD, U.S.A.
3:00 PM 
133  Potential Of Hydrophobic Amino 
Acid Tryptophan As An Absorption 
Enhancer For The Oral Delivery Of 
Biopharmaceuticals 
N. Kamei, H. Tamiwa, M. Miyata, M. 
Takeda-Morishita; Kobe Gakuin Univ., 
Kobe, Japan
3:15 PM 
462  Mechanistic Modeling And Prediction 
Of The Effect Of Food On Oral Drug 
Absorption 
O. Rezhdo, L. S. Speciner, R. L. Carrier; 
Northeastern Univ., Boston, MA, U.S.A.
REFRESHMENT BREAK 
3:30 PM – 4:00 PM | Rhinelander Gallery
AWARDS AND CLOSING CEREMONY 
4:00 PM – 4:30 PM | Grand Ballroom
Awards will be given out for best poster and oral presentations. 
Passport 2 Prizes game winners will be announced, winners must be present to win
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CONNECT @ the  EXPO
Exposition Hall (Rhinelander Gallery)
The CRS Exposition is the place to CONNECT and discover the latest delivery science and technology trends! Meet face-to-
face with leading companies from around the world—learn about new products, discuss industry challenges, and build your 
network. 2018 Exhibitors as of (6/1/2018)
Detailed description of current Exhibitors and the schedule of Exposition hours can be found in the CRS Meeting App.
COMPANY NAME ........................................ BOOTH #
Absorption Systems ....................................................17
Advanced Polymer Materials Inc. ...............................36
Agilent Technologies ..................................................56
Anton Paar USA ..........................................................52
ARx, LLC/Adhesives Research ....................................28
Ashland  ......................................................................5




DigiM Solution LLC ....................................................33
Dolomite Microfluids ..................................................45
Drug Delivery Experts ................................................27
DURECT Corp/LACTEL Absorbable Polymers ...........54
Elsevier .......................................................................10
Evonik Corporation ....................................................60
Foster Delivery Science ..............................................51
Gattefosse ..................................................................61
Gaylord Chemical Company LLC ...............................32
IPEC-Americas ............................................................23
Izon Science ................................................................7
JenKem Technology USA ...........................................38
Lipoid LLC ..................................................................57
Logan Instruments ......................................................35
Lonza Pharma & Biotech ............................................65
Lubrizol LifeSciences ..................................................46
Malvern Pananalytical .................................................48
Microfluidics International Corporation ......................66
COMPANY NAME ........................................ BOOTH #
MilliporeSigma ...........................................................49
NanoImaging Services ................................................40













Shin-Etsu Chemical Co. ..............................................67
Shin Nippon Biomedical Laboratories, Ltd. ...............22
Simulations Plus, Inc. ..................................................50
SOTAX ........................................................................63
Southwest Research Institute ......................................2
Springer ......................................................................9
SPI Pharma .................................................................29
Suven Life Sciences Limited  ......................................37
Teledyne Hanson Research .........................................3
tesa Labtec GmbH .....................................................8
Texture Technologies ..................................................31
Thinky USA .................................................................42
Ursatec Verpackung GmbH ........................................47
Wyatt Technology  ......................................................44
COLLABORATE • CONNECT • INNOVATE
Exhibit Hall Hours
Sunday  5:00 PM - 7:00 PM Monday  9:00 AM - 4:30 PM 
5:00 PM - 6:00 PM
Tuesday  9:00 AM - 4:00 PM
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SPONSORS  of  the  2018 CRS 
ANNUAL MEETING &  EXPOSITION
Agilent 
Agilent offers a strong portfolio of pharmaceutical 
dissolution testing products. Our Cary systems meet 
harmonized USP, EP, and JP guidance and integrate the 
latest technologies for product formulation and other 
applications. Our dissolution product range now provides 
one of the most extensive selections of physical testing 
equipment. www.agilent.com
Ashland 
At Ashland, our goal is to help you apply pharmaceutical 
polymers to develop your formulations. Our molecular 
scientists, chemists, formulators and process engineers 
can help advance complex oral solid, liquid and parenteral 
dosage formulations. Our problem-solving team leverages 
a diverse polymer excipient and film coatings portfolio to 
provide comprehensive solutions, so when you’re ready to 
formulate, we’re ready to help.
AstraZeneca 
AstraZeneca is a leading global biopharmaceutical 
company. At AstraZeneca, we discover, develop, 
manufacture and market small molecules and biologics 
focused on three key areas – oncology; cardiovascular 
and metabolic diseases; and respiratory, inflammation 
and autoimmunity. AstraZeneca’s is a science leader with 
a mission to turn ideas into life-changing medicines that 
improve patients’ lives and benefit society.
Balda Medical 
Balda and Ompi represent the Pharmaceutical Systems 
division of the international Stevanato Group. Balda is 
a specialist for plastics solutions for the pharmaceutical, 
diagnostics and medical device industries, focusing on multi-
component high precision injection molding and automated 
system assembly. Being a one-stop solution provider, the 
range of capabilities is broad - From product development 
to the delivery of a final product, packed and sterilized where 
appropriate. Beyond the CDMO activities, Balda is proactively 
taking the next step in drug delivery systems: a pharmaceutical 
product portfolio, based on profound development 
competence, completes the product and service offering. 
Exceptional product quality and high volume production in 
Germany and USA are some of the outstanding characteristics 
for Balda’s products and solutions made in plastics
BASF 
BASF creates chemistry for a sustainable future offering 
intelligent solutions to the pharmaceutical industry. With 
expertise in polymer chemistry, R&D-capabilities and 
commitment in developing excipients, BASF creates 
solutions for Instant & Modified Release, Solubilization, 
Softgels and Skin Delivery. BASF is the leading supplier of 
APIs such as ibuprofen and omega-3.
Boehringer Ingelheim Pharmaceuticals, Inc., 
Boehringer Ingelheim Pharmaceuticals, Inc., the US 
subsidiary of Boehringer Ingelheim, headquartered in 
Germany, operates globally in 45 countries with nearly 
36,000 employees. The company is committed to 
researching, developing, manufacturing and marketing 
novel products of high therapeutic value for human and 
veterinary medicine. http://us.boehringer-ingelheim.com
Bosch 
Bosch is your single-source supplier of process technology 
and packaging solutions for the pharmaceutical industry. The 
portfolio includes single units, complete lines and integrated 
systems for the manufacturing and processing of liquid 
and solid pharmaceuticals. Bosch offers full-range service 
solutions with a strong global network acting on a local basis.
Thank You Sponsors
CRS Sponsors help bring you the novel science and networking opportunities you expect from your annual meeting. 
Please be sure to thank our 2018 Sponsor when you see them. We are so grateful for their continued support of  




Catalent is the leading global provider of advanced 
delivery technologies and development solutions for 
drugs, biologics, and consumer health products. With over 
80 years serving the industry, Catalent has proven expertise 
in bringing more customer products to market faster, 
enhancing product performance, and ensuring reliable 
clinical and commercial product supply.
Colorcon with Dow Pharma 
Colorcon with Dow Pharma - Unique Together. Through 
the Controlled Release Alliance, Colorcon and Dow have 
collaborated to serve the needs of the pharmaceutical 
industry, since July 2007. The global CR alliance brings 
joint resources to accelerate your pharmaceutical 
product development by providing customized solutions, 
innovative products, and support services.
Drug Delivery Experts 
Drug Delivery Experts is a premier lab facility located in 
San Diego, California that specializes in drug product 
development. We have the expertise to integrate 
formulations that best match delivery system and device; 
all while maximizing commercial potential.
Eli Lilly & Company  
Three established core values guide Lilly in all that we 
do. Integrity: We conduct our business consistent with 
all applicable laws and are honest in our dealings with 
customers, employees, shareholders, partners, suppliers, 
competitors and the community. Excellence: We pursue 
pharmaceutical innovation, provide high quality products 
and strive to deliver superior business results. Respect 
for People: We maintain an environment built on mutual 
respect, openness and individual integrity. Respect for 
people includes our concern for all people who touch 
or are touched by our company: customers, employees, 
shareholders, partners, suppliers and communities.
Evonik Corporation 
Evonik, a global leader in specialty chemicals, provides drug 
delivery technologies, API manufacturing, intermediates & 
amino acids. Delivery technologies include development 
services, solubility enhancement, functional excipients, 
lipid nanoparticles, and GMP manufacturing for oral and 
parenteral formulations. Advanced delivery technologies 
provided for small molecules, peptides, proteins, antibodies, 
and nucleic acids used in parenteral drugs.
Gattefossé 
Gattefossé is a global provider of excipients and innovative 
solutions for enhancing drug delivery. Product offerings 
include solubility, permeability, and bioavailability 
enhancers; inert drug carriers; and matrices for immediate, 
enhanced, or modified release formulations. Our team of 
experts is available for formulation, regulatory, and quality 
by design support for customers.
DURECT Corp/LACTEL Absorbable Polymers 
Visit LACTEL exhibit #54 to learn about our biodegradable 
polymers optimized for use in sustained release delivery 
systems, including targeted delivery, nucleic acid 
administration, and more. We offer an extensive inventory, 
and substantial expertise in custom synthesis. LACTEL 
polymers are in numerous marketed pharmaceuticals 
approved by the FDA and others.
Lonza Pharma & Biotech 
Lonza Pharma & Biotech provides global contract 
development and manufacturing services that enable 
pharma and biotech companies to bring medical innovations 
to patients in need. We are recognized for our reliability and 
high-quality, our global capacity, our innovative technology 
platforms, and our extensive experience. We have helped 
to commercialize pioneering therapies and we continuously 
invest and innovate to meet your expectations also for 
future medicines. Our belief is that the best outcome –for 
you and for your patients –comes as a result of a successful 
collaboration. Together, we can solve the next challenge and 
bring your next medicine to life.




Malvern Panalytical is a leader in analytical characterization, 
creating expert solutions for the challenges associated 
with maximizing productivity, developing better quality 
products and getting them to market faster. We provide 
superior, customer-focused solutions and services which 
deliver tangible economic impact through chemical, 
biophysical and structural analysis. www.malvern.com
Merck 
For 125 years, Merck has been a global health care leader 
working to help the world be well. Merck is known as  
MSD outside the United States and Canada. Through 
our  prescription medicines, vaccines, biologic therapies, 
and animal health products, we work with customers and 
operate in more  than 140 countries to deliver innovative 
health solutions. We also demonstrate our commitment 
to increasing access to health care through far-reaching 
policies, programs and partnerships. Connect with us on 
Twitter, Facebook, YouTube and LinkedIn. www.merck.com.
Novo-Nordisk 
Novo Nordisk is a global healthcare company with more 
than 90 years of innovation and leadership in diabetes care. 
This heritage has given us experience and capabilities that 
also enable us to help people defeat other serious chronic 
conditions: haemophilia, growth disorders and obesity.
Orbis Biosciences 
Orbis Biosciences’ Precision Particle Fabrication® 
technology provides customized solutions for taste 
masking, extended release, enteric coatings, and pulsatile 
release. This proprietary, single step manufacturing process 
creates uniform microparticles that optimize oral and 
injectable pharmaceuticals. Orbis offers robust intellectual 
property, formulation development, cGMP Phase 1 
manufacturing, and scaled technology.
Pfizer Inc. 
At Pfizer, we strive to set the standard for quality, 
safety and value in the discovery, development and 
manufacturing of medicines for people. Every day Pfizer 
colleagues work across developed and emerging markets 
to advance wellness, prevention, treatments, and cures that 
challenge the most feared diseases of our time.
Recro Gainsville 
Recro is the solid oral dose expert specializing in controlled 
substance and extended release formulations to your exact 
standards. No matter the scope of your project, we deliver 
— streamlining product formulation and manufacturing 
from concept to clinic to commercial scale.
Ronald T. Dodge Company 
The Ronald T. Dodge Company is a leader in the “Innovative 
Art & Science of Microencapsulation and Controlled 
Release” and a trusted quality source of encapsulated 
products for our diverse customers. Uning creative 
encapsulation techniques, we provide microcapsule services 
for a wide variety of customer needs. rtdodge.com
SPI Pharma 
Pharma and nutraceutical customers use our ingredients 
to provide convenience, compliance, safety and efficacy 
to patients globally. Our product offering includes antacid 
actives, excipients, drug delivery systems, taste masked 
actives, vaccine adjuvants, and drug development services. 
We can make finished drugs work better. Let’s solve your 
formulation challenge together.
Suven Life Sciences Limited 
Suven Life Sciences has 16 years experience in discovery 
and development of several small molecules to clinic 
in CNS. Suven offers GLP compliant drug development 
services from discovery through Phase III. Suven is a 
collaborative development partner providing the most 
comprehensive exploratory preclinical services specialized 





Dissolution Technologies is an international, peer-reviewed, 
indexed quarterly journal reporting dissolution-related 
current information and scientific articles. The website, 
www.dissolutiontech.com, is searchable and contains the 
current and all back issues with articles available for free as 
a PDF download. Dissolution Technologies is celebrating 
twenty years of publishing this open access journal. 
www.dissolutiontech.com
Drug Development and Delivery 
Looking to publish your research? Discover Springer’s print 
and electronic publication services, including open access! 
Get high-quality review, maximum readership and rapid 
distribution. Visit our booth or springer.com/authors. You 
can also browse key titles in your field and buy (e)books at 
discount prices. With Springer you are in good company.
MDPI Pharmaceutics 
Pharmaceutics is an academic open access journal 
published by MDPI. It provides an interdisciplinary forum 
for publications which advance the fields of (i) formulation 
and dosage form design, (ii) drug delivery and related 
biotechnology, and (iii) biopharmaceutics. Pharmaceutics is 
indexed by SCIE, PubMed and Scopus. Read for FREE at: 
http://www.mdpi.com/journal/pharmaceutics
On Drug Delivery 
ONdrugDelivery Magazine is the only publication that 
focuses tightly on one specific topic within the field of 
drug delivery with each issue. Established for eleven years, 
ONdrugDelivery is available in print and free electronic 
versions. With a truly global readership in excess of 30,000, 
and with contributions and loyal support from many of the 
most important companies in the drug delivery business - 
from among the largest to the smallest - ONdrugDelivery 
Magazine is a must for those in the industry who need 
to know what’s going on in drug delivery worldwide. 
Subscribe today at: www.ondrugdelivery.com
Journal of Controlled Release 
(Elsevier) 
Elsevier is a global information 
analytics company that helps 
institutions and professionals progress 
science, advance healthcare and improve performance for 
the benefit of humanity. We help researchers make new 
discoveries, collaborate with their colleagues, and give 
them the knowledge they need to find funding.
Springer 
Looking to publish your research? Discover Springer’s print 
and electronic publication services, including open access! 
Get high-quality review, maximum readership and rapid 
distribution. Visit our booth or springer.com/authors. You 
can also browse key titles in your field and buy (e)books at 
discount prices. With Springer you are in good company.
The Medicine Maker 
The Medicine Maker is a global magazine focused on the 
development and manufacture of both pharmaceutical and 
biopharmaceutical products. The editorial style is practical, 
pragmatic, and meaningful to the daily working life of all 
professionals in the clinical, regulatory, development, and 
manufacturing fields. It helps professionals to do their job 
better. Feature articles tell the stories behind the biggest 
concepts, innovations, challenges, and advances in the 
field. themedicinemaker.com
COLLABORATE • CONNECT • INNOVATE
Wyatt Technologies 
Wyatt Technology® is the recognized leader in instrumentation for determining the absolute 
molar mass, size, charge and interactions of macromolecules and nanoparticles in solution. 
These tools include: in-line multi-angle static light scattering, high-throughput dynamic light 
scattering, differential refractometry, electrophoretic mobility, differential viscosity, field flow 





COLLABORATE • CONNECT • INNOVATE
29
 
30
NOTES


